Please login to the form below

Not currently logged in
Email:
Password:

BMS appoints Saurabh Saha as senior VP, global head of translational medicine

He joins the R&D team from Atlas Venture

Saurabh SahaBristol-Myers Squibb (BMS) has appointed Saurabh Saha as its new senior vice president, global head of translational medicine in the company’s R&D unit.

Initially based at the pharma giant’s site at Waltham, Massachusetts until its new  research facility opens in Cambridge, Massachusetts, Saha will lead translational research to ensure disease understanding and asset-specific biology.

He said: “Throughout my career, I have had a passion for developing translational research strategies across disease areas, including oncology and immunology.

“I look forward to working with the R&D organisation to advance BMS’ industry-leading pipeline in a way that pushes the boundaries of science and enables us to rapidly deliver innovative medicines to patients with even greater precision.”

Saha’s expertise includes leading translational research and implementing drug discovery strategies that have resulted in the discovery and development of two first-in-class cancer therapies and the pioneering of new approaches for unmet medical needs across therapeutic areas and clinical modalities.

Prior to joining BMS, Saha was a partner at Atlas Venture, where he held numerous leadership positions with several of its portfolio biotech companies, including chief medical officer of Synlogic and chief executive officer of Delinia until its sale to Celgene.

He has also established translational research and development organisation BioMed Valley discoveries where he served as chief scientific officer and later president.

His other roles include consultant at McKinsey and Company and director and head of the new indications discovery unit at Novartis.

Tom Lynch, executive vice president and chief scientific officer, BMS, said: “Enhancing our translational medicine capability is critical to achieving our mission, and we are excited to add Dr. Saha’s broad leadership expertise to our team.”

12th October 2017

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics